12-2651630-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_001129829.2(CACNA1C):c.4002C>T(p.Asp1334Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 0 hom. )
Consequence
CACNA1C
NM_001129829.2 synonymous
NM_001129829.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.180
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 12-2651630-C-T is Benign according to our data. Variant chr12-2651630-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 308149.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-2651630-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.18 with no splicing effect.
BS2
High AC in GnomAd4 at 13 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000344100.7 | c.4002C>T | p.Asp1334Asp | synonymous_variant | Exon 32 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000399603.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
CACNA1C | ENST00000399655.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
CACNA1C | ENST00000682544.1 | c.4180-10C>T | intron_variant | Intron 33 of 49 | ENSP00000507184.1 | |||||
CACNA1C | ENST00000406454.8 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 5 | ENSP00000385896.3 | ||||
CACNA1C | ENST00000399634.6 | c.3913-10C>T | intron_variant | Intron 30 of 46 | 5 | ENSP00000382542.2 | ||||
CACNA1C | ENST00000683824.1 | c.4111-10C>T | intron_variant | Intron 32 of 47 | ENSP00000507867.1 | |||||
CACNA1C | ENST00000347598.9 | c.4090-10C>T | intron_variant | Intron 33 of 48 | 1 | ENSP00000266376.6 | ||||
CACNA1C | ENST00000327702.12 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 1 | ENSP00000329877.7 | ||||
CACNA1C | ENST00000399617.6 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 5 | ENSP00000382526.1 | ||||
CACNA1C | ENST00000682462.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507105.1 | |||||
CACNA1C | ENST00000683781.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507434.1 | |||||
CACNA1C | ENST00000683840.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507612.1 | |||||
CACNA1C | ENST00000683956.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000506882.1 | |||||
CACNA1C | ENST00000399638.5 | c.4030-10C>T | intron_variant | Intron 32 of 47 | 1 | ENSP00000382547.1 | ||||
CACNA1C | ENST00000335762.10 | c.4021-10C>T | intron_variant | Intron 32 of 47 | 5 | ENSP00000336982.5 | ||||
CACNA1C | ENST00000399606.5 | c.4006-10C>T | intron_variant | Intron 32 of 47 | 1 | ENSP00000382515.1 | ||||
CACNA1C | ENST00000399621.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382530.1 | ||||
CACNA1C | ENST00000399637.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382546.1 | ||||
CACNA1C | ENST00000402845.7 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000385724.3 | ||||
CACNA1C | ENST00000399629.5 | c.3997-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382537.1 | ||||
CACNA1C | ENST00000682336.1 | c.3988-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507898.1 | |||||
CACNA1C | ENST00000399591.5 | c.3913-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382500.1 | ||||
CACNA1C | ENST00000399595.5 | c.3913-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382504.1 | ||||
CACNA1C | ENST00000399649.5 | c.3907-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382557.1 | ||||
CACNA1C | ENST00000399597.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382506.1 | ||||
CACNA1C | ENST00000399601.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382510.1 | ||||
CACNA1C | ENST00000399641.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382549.1 | ||||
CACNA1C | ENST00000399644.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382552.1 | ||||
CACNA1C | ENST00000682835.1 | c.3946-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507282.1 | |||||
CACNA1C | ENST00000683482.1 | c.3937-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507169.1 | |||||
CACNA1C | ENST00000682686.1 | c.3913-10C>T | intron_variant | Intron 30 of 45 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152150Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249314Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135248
GnomAD3 exomes
AF:
AC:
12
AN:
249314
Hom.:
AF XY:
AC XY:
5
AN XY:
135248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461666Hom.: 0 Cov.: 33 AF XY: 0.0000413 AC XY: 30AN XY: 727130
GnomAD4 exome
AF:
AC:
61
AN:
1461666
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74330
GnomAD4 genome
AF:
AC:
13
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Benign:1
Dec 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at